منابع مشابه
Treatment of Meningeal Malignancy.
Meningeal metastasis from cancer has become an increasingly frequent problem as the treatment of systemic disease improves. Leukemia, lymphoma and solid tumors may all metastasize to the meninges, where the blood-brain barrier may provide a sanctuary from cytotoxic concentrations of chemotherapeutic agents. Because meningeal disease may be clinically silent or may present with unusual signs and...
متن کاملCerebrospinal fluid tumour markers in patients treated for meningeal malignancy.
The results of cerebrospinal fluid (CSF) biochemical markers were compared with conventional CSF cytology in patients treated for leptomeningeal metastases from extra cranial malignancies. For lumbar CSF, before treatment, no statistically significant difference of the probabilities of being positive was found between CSF cytology and a classification by linear discriminant analysis, based on p...
متن کاملTreatment of meningeal leukemia with pyrimethamine.
Pyrimethamine, a substituted pyrimidine trations of pyrimethamine were 10-25% with potent folate antagonistic properof the simultaneous plasma concentraties, was given orally to treat two epitions. Considerations regarding lipid solsodes of meningeal leukemia in a longubility, body distribution, and easily term survivor with acute myeloblastic reversible toxicity of pyrimethamine sugleukemia. R...
متن کاملReview Article: Effect of Medicinal Herbs in the Treatment of Thyroid Malignancy
Thyroid cancer is the most common endocrine malignant tumor, and its incidence is on the rise. A survey conducted by the Iranian Cancer Institute showed that thyroid cancer constitutes 1.8% of all cancers and 76.1% of endocrine cancers. A lot of studies are being conducted in order to prevent, alleviate pain, and treat cancer using medicinal herbs. Medicinal herbs are important sources of, and ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Oncologist
سال: 1996
ISSN: 1083-7159,1549-490X
DOI: 10.1634/theoncologist.1-1-56